Nick Paul TaylorSequencingNanopore sequencing slashes tumor analysis times and costsNanopore sequencing makes the analysis of copy number variations (CNVs) faster, cheaper, and simpler, according to a preprint paper from researchers at Dartmouth-Hitchcock Medical Center.November 28, 2023Coronary Artery DiseaseAI-powered blood test supports risk stratification of heart disease patientsA blood test powered by artificial intelligence (AI) has shown promise in the assessment of patients with total blockage of a heart artery.November 27, 2023Artificial IntelligenceAI concurs with humans in heart failure test, suggesting scalable approach to clinical trialsArtificial intelligence (AI) may make clinical trials more efficient by accurately identifying events at scale, a retrospective analysis has found.November 21, 2023Regulatory ApprovalFDA plans to increase oversight of LDTs garner strong responsePlans to increase U.S. Food and Drug Administration (FDA) oversight of laboratory-developed tests (LDTs) have drawn a strong response from trade groups, individuals, and organizations.November 17, 2023BiosensorsNetworks of wearable sensors capture body sounds to improve patient monitoringResearchers have developed soft, miniaturized wearable devices to continuously capture the sounds of breathing and other bodily functions.November 16, 2023Breast CancerFragment of C. diff toxin shows preclinical promise as breast cancer treatmentA fragment of a Clostridium difficile toxin could improve outcomes in patients with hard-to-treat forms of breast cancer, according to a paper published in PLOS Biology.November 13, 2023SequencingBlood test for biomarker offers route to affordable cancer screeningResearchers have developed a sensitive blood test for a highly specific biomarker of multiple common tumors, laying the groundwork for a product that could improve cancer screening.November 6, 2023SequencingOxford Nanopore partners with Fabric Genomics on assessment of genetic disease in childrenOxford Nanopore Technologies and Fabric Genomics have teamed up to provide a sequencing analysis platform for neonatal and pediatric intensive care units.November 1, 2023Gene silencing and gene editingSoftware reduces DANGER of CRISPR-Cas9 by shedding light on off-target editsA new software can improve the safety and utility of CRISPR-Cas9 gene editing by detecting off-target changes and eliminating the need for reference genomes, according to a paper published in Bioinformatics Advances.October 27, 2023SequencingPharma companies back project to create largest African ancestry genomics research databaseAstraZeneca, Novo Nordisk, Regeneron, and Roche have backed a project to create the largest African ancestry genomics research database.October 25, 2023Page 1 of 15Next PageTop StoriesArtificial IntelligenceAI model could prevent unnecessary treatment for breast cancer patients, says studyBreast cancer patients could be spared unnecessary chemotherapy with the use of a new artificial intelligence (AI) tool that helps predict survival risk, say researchers.FDA ClearanceKSQ Therapeutics receives FDA clearance for trial of CRISPR-Cas9 engineered tumor therapyVascular DiseasePotential drug target to prevent small vessel disease identified in studyTrends and FinanceCandel Therapeutics to lay off 50% of workforce, refocus on advanced oncology immunotherapiesRheumatoid ArthritisScipher Medicine, Quest Diagnostics collaborate on RA diagnostics
